CAMK2G and cancer: We used myristoylated autocamtide-2-related inhibitory peptide (AIP), an inhibitor of CaMKII, and recombinant Wnt5A protein (to activate Wnt signaling) in normal and cancer cells to test these hypotheses (Fig. 5).